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PCardiac Resynchronization Therapy
Optimal Left Ventricular Lead
Position Predicts Reverse Remodeling and
Survival After Cardiac Resynchronization Therapy
Claudia Ypenburg, MD,* Rutger J. van Bommel, MD,* Victoria Delgado, MD,*
Sjoerd A. Mollema, MD,* Gabe B. Bleeker, MD, PHD,* Eric Boersma, PHD,†
Martin J. Schalij, MD, PHD,* Jeroen J. Bax, MD, PHD*
Leiden and Rotterdam, the Netherlands
Objectives The aim of the current study was to evaluate echocardiographic parameters after 6 months of cardiac resynchro-
nization therapy (CRT) as well as long-term outcome in patients with the left ventricular (LV) lead positioned at
the site of latest activation (concordant LV lead position) as compared with that seen in patients with a discor-
dant LV lead position.
Background A nonoptimal LV pacing lead position may be a potential cause for nonresponse to CRT.
Methods The site of latest mechanical activation was determined by speckle tracking radial strain analysis and related to
the LV lead position on chest X-ray in 244 CRT candidates. Echocardiographic evaluation was performed after
6 months. Long-term follow-up included all-cause mortality and hospitalizations for heart failure.
Results Significant LV reverse remodeling (reduction in LV end-systolic volume from 189  83 ml to 134  71 ml, p 
0.001) was noted in the group of patients with a concordant LV lead position (n  153, 63%), whereas patients
with a discordant lead position showed no significant improvements. In addition, during long-term follow-up
(32  16 months), less events (combined for heart failure hospitalizations and death) were reported in patients
with a concordant LV lead position. Moreover, a concordant LV lead position appeared to be an independent pre-
dictor of hospitalization-free survival after long-term CRT (hazard ratio: 0.22, p  0.004).
Conclusions Pacing at the site of latest mechanical activation, as determined by speckle tracking radial strain analysis,
resulted in superior echocardiographic response after 6 months of CRT and better prognosis during long-term
follow-up. (J Am Coll Cardiol 2008;52:1402–9) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.06.046i
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ahe rationale for cardiac resynchronization therapy (CRT)
or the treatment of severe congestive heart failure is to
oordinate the contraction of the dyssynchronous dilated
eart, thereby improving left ventricular (LV) systolic func-
ion. Several large randomized studies demonstrated that
RT not only improves clinical status but also reverses
V remodeling (1–5). However, a significant percentage
f patients do not show benefit from CRT (2,6). Differ-
nt factors may influence the likelihood of response to
RT, such as lack of baseline mechanical dyssynchrony,
rom the *Department of Cardiology, Leiden University Medical Center, Leiden, the
etherlands; and the †Department of Epidemiology and Statistics, Erasmus Univer-
ity, Rotterdam, the Netherlands. Dr. Delgado was supported by a grant from the
uropean Society of Cardiology. Dr. Bleeker was supported by the Dutch Heart
oundation, grant no: 2002B109. Dr. Schalij received research grants from Biotronik,
edtronic, and Boston Scientific. Dr. Bax received research grants from GE
ealthcare, BMS Medical Imaging, Boston Scientific, Medtronic, and St. Jude.
andall C. Starling, MD, MPH, FACC, served as Guest Editor for this article.m
Manuscript received March 26, 2008; revised manuscript received June 2, 2008,
ccepted June 17, 2008.nsufficient device programming, and suboptimal LV lead
osition (7,8).
See page 1410
Currently, the LV pacing lead is positioned preferably in
lateral or posterolateral branch of the coronary sinus. This
pproach is based on initial studies, which demonstrated
hat a (postero)lateral position of the LV pacing lead yielded
reater acute hemodynamic benefit as compared with an
nterior LV lead position (9). However, a few studies show
o difference in long-term follow-up between patients with
lead in the anterior versus a posterolateral position
10–12). In addition, it has been shown that the region of
aximal mechanical delay varies significantly between pa-
ients and may involve other sites remote of these branches
13). It has been suggested that positioning of the LV lead
t the site of latest mechanical activation may result in
aximum benefit of CRT (13–17).
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October 21, 2008:1402–9 LV Lead Position and Response to CRTThe aim of the current study was to evaluate clinical and
chocardiographic 6-month outcome as well as long-term
rognosis in a large cohort of patients by comparing patients
ith the LV lead positioned in the region of latest mechan-
cal activation with patients with the LV positioned outside
he site of latest mechanical activation. Two-dimensional
2D) speckle tracking radial strain analysis was used to
etermine the presence of LV dyssynchrony and the region of
atest mechanical activation.
ethods
atients and study protocol. Two-hundred fifty-seven
onsecutive patients with advanced heart failure (New York
eart Association [NYHA] functional class III or IV),
epressed left ventricular ejection fraction (LVEF) (35%),
nd wide QRS complex (120 ms) were prospectively
ncluded for implantation of a CRT device (18). Patients
ith a recent myocardial infarction (3 months) or decom-
ensated heart failure were excluded. Etiology was consid-
red ischemic in the presence of significant coronary artery
isease (50% stenosis in 1 or more of the major epicardial
oronary arteries) and/or a history of myocardial infarction
r prior revascularization.
The study protocol was as follows: before implantation,
esting transthoracic echocardiography was performed to
easure LVEF and LV volumes. Next, 2D speckle tracking
adial strain analysis was performed to determine the extent
f LV dyssynchrony as well as the site of latest mechanical
ctivation. Clinical status was assessed at baseline and after
months of CRT, including assessment of NYHA func-
ional class, quality-of-life score (using the Minnesota
iving with Heart Failure questionnaire) (19), and evalua-
ion of exercise capacity using the 6-min walking test (20).
t the 6-month follow-up, LV volumes and LVEF were
eassessed. Hospitalization for decompensated heart failure
nd survival and cardiac transplantation were assessed dur-
ng follow-up after CRT device implantation.
chocardiography and data acquisition/analysis. Echo-
ardiographic images were obtained with a 3.5-MHz
ransducer in the left lateral decubitus position using a
ommercially available system (Vivid Seven, General
lectric-Vingmed, Milwaukee, Wisconsin). Standard 2D
nd color Doppler data, triggered to the QRS complex,
ere saved in cine-loop format for off-line analysis
EchoPac 6.06, GE Medical Systems, Horten, Norway).
Left ventricular end-diastolic volume (LVEDV) and left
entricular end-systolic volume (LVESV) were derived, and
VEF was calculated from the conventional apical 2- and
-chamber images, using the biplane Simpson’s technique
21). The severity of mitral regurgitation was graded semi-
uantitatively from color-flow Doppler images using the
pical 4-chamber views. Mitral regurgitation was graded on
3-point scale: mild (jet area/left atrial area 20%),
oderate (jet area/left atrial area 20% to 45%), and severejet area/left atrial area 45%) (22). cLV dyssynchrony was assessed
sing 2D speckle tracking radial
train analysis on baseline mid-
entricular short-axis images
23,24). All the images were re-
orded with a frame rate of at
east 30 frames/s to allow for
eliable operation of the software
EchoPac 6.1, GE Medical Sys-
ems). Time-strain curves for the
segments (septal, anteroseptal,
nterior, posterior, lateral, and in-
erior) were constructed (Fig. 1).
imes from QRS onset to peak
adial strain were obtained for all
segments, and reliable curves
ere obtained in 92% of 1,542
ttempted segments. Conse-
uently, the location of the ear-
iest and latest activated seg-
ents and the heterogeneity in time-to-peak radial strain
or the 6 segments were determined (25). LV dyssynchrony
as defined as the maximal time difference between the
arliest and latest activated segments. The site of latest
echanical activation was also noted. Inter- and intraob-
erver variability for the assessment of the site of latest
ctivation showed a good agreement, with, respectively,
0% and 83% of the segments scored identically (  0.71
nd   0.76).
esponse to CRT and long-term follow-up. Echo-
ardiographic and clinical improvement was assessed after 6
onths of CRT. Patients were classified as responders to
RT (‘responders’) if they showed a decrease of 15% in
VESV (26,27). The remaining patients, including those
ho died during the 6-month follow-up period, were
lassified as ‘non-responders.’
Long-term follow-up was performed by chart review,
evice interrogation, and telephone contact. Events were
efined as follows: death from any cause or cardiac trans-
lantation and heart failure requiring hospitalization. The
rimary end point was the composite of death, cardiac
ransplantation, and hospitalization for decompensated
eart failure.
RT implantation and LV lead position. A coronary
inus venogram was obtained using a balloon catheter,
ollowed by the insertion of the LV pacing lead. An 8-F
uiding catheter was used to position the LV lead (Easytrak
512-80, Guidant Corporation, St. Paul, Minnesota; or
ttain-SD 4189, Medtronic Inc., Minneapolis, Minnesota)
n the coronary sinus. The preferred position was a lateral or
osterolateral vein (28). Of note, the electrophysiologist was
linded for all echocardiographic data, so LV lead position-
ng was not guided by the echocardiographic information on
atest mechanical activation.
The right atrial and ventricular leads were positioned
Abbreviations
and Acronyms
CI  confidence interval
CRT  cardiac
resynchronization therapy
HR  hazard ratio
LV  left ventricle/
ventricular
LVEDV  left ventricular
end-diastolic volume
LVEF  left ventricular
ejection fraction
LVESV  left ventricular
end-systolic volume
NYHA  New York Heart
Association
PH  proportional hazards
2D  two-dimensionalonventionally. All leads were connected to a dual-chamber
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LV Lead Position and Response to CRT October 21, 2008:1402–9iventricular implantable cardioverter-defibrillator (Contak
enewal II or H195, Guidant Corporation; or Insync III or
nsync Sentry, Medtronic Inc.).
One day after implantation, the LV lead position was
ssessed from a chest X-ray (29). The LV lead positions
ere scored anterior, lateral, posterior, or inferior using the
ateral views. Only LV lead positions that were located in
he basal and midregion of the LV (frontal views) were
elated to the site of latest mechanical activation model
midventricular short-axis view); LV lead positions that
ere located in the apical regions were excluded from
urther analysis. LV lead positions were classified as ‘con-
ordant’ when the lead was positioned at the latest activated
egment; in case of differences between the LV lead position
nd site of latest mechanical activation, these positions were
LATERAL
POSTERIOR
INFERIOR
SEPTAL
ANTERO-SEPTAL
A
ANTERIOR
LV dyssynchrony 220 ms
Site of latest activationB
Figure 1 Speckle Tracking Radial Strain Analysis
(A) Short-axis of the left ventricle (LV) at the level of the papillary muscles,
with reconstruction of the 6 LV segments. (B) Demonstrates the separate
strain-time curves for each individual segment. In this patient example, severe
baseline LV dyssynchrony was present; a maximum delay of 220 ms was cal-
culated between the septum (red) and the posterior wall (purple). Site of lat-
est activation was the posterior LV segment (purple) AVC  aortic valve
closure.lassified as ‘discordant.’ Interobserver and intraobserver igreement for the assessment of LV lead position was
xcellent with both 91% LV lead positions scored identically
  0.88).
tatistical analysis. Continuous variables are expressed as
ean  SD. Categorical data are summarized as frequen-
ies and percentages. Differences in baseline characteristics
etween patients with concordant and discordant LV lead
ositions were analyzed using unpaired Student t tests
continuous variables) and chi-square or Fisher exact tests
dichotomous variables) as appropriate. The paired Student
test was used to compare continuous data within the
ubgroups during follow-up. Interobserver and intraobserver
greement for assessment of the site of latest activation and
V lead position were calculated, and  values were deter-
ined (0.40 poor agreement, 0.40 to 0.75 fair to good,
nd 0.75 excellent).
Event and survival curves were determined according to
he Kaplan-Meier method, with comparisons of cumulative
vent rates by the log-rank test. To adjust for (potential)
onfounding factors for LV lead position such as age,
ender, etiology, NYHA functional class, QRS duration,
eft bundle branch block configuration, cardiac rhythm, LV
olumes, and LV dyssynchrony, univariable and multivari-
ble Cox proportional hazards (PH) analysis was performed.
ll variables entered the multivariable stage, irrespective of
he results of the univariable analyses. Multivariable regres-
ion was then performed according to the principle of back-
ard deletion. All variables with a p value of 0.15 remained
n the final model. Adjusted hazard ratios (HRs) with their
5% confidence intervals (CIs) are reported. For all tests, a p
alue 0.05 was considered statistically significant.
To check the PH assumption, log(log[survival proba-
ility]) was plotted against time for patients with concor-
ant versus discordant LV lead position. Similar plots were
reated for (different categories of) potential confounders.
he curves were reasonably parallel for all variables studied,
ndicating that the proportionality assumptions were not
iolated. However, there were 2 exceptions: there was
vidence that the PH assumption was violated for the
elation between LV lead position and the single end point
ospitalization for heart failure, and the composite end
oint of all-cause death, cardiac transplant, or hospitaliza-
ion for heart failure. Since the event curves representing
he latter end point diverged at 24-month follow-up (see the
esults section), we decided to report separate HRs for the
rst 24 months and the subsequent period.
esults
atients. Baseline characteristics of the 257 consecutive
atients (211 men, mean age 66 10 years) included in this
tudy are summarized in Table 1. Patients had severely
epressed LV function, with a mean LVEF of 24  7%.
ean LVEDV was 232  86 ml, and mean LVESV was
80  76 ml. Severe LV dyssynchrony was present, as
ndicated by a maximal delay of 177  117 ms. The site of
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October 21, 2008:1402–9 LV Lead Position and Response to CRTatest mechanical activation was most frequently located in
he lateral (84 patients, 33%) and posterior segments (93
atients, 36%) (Fig. 2).
Device implantation was successful in all patients, and no
rocedure-related complications were reported. Most LV
acing leads were positioned in the basal-midventricular
egion, including the lateral region in 111 patients (45%),
he posterior region in 119 patients (49%), and the anterior
egion in 14 patients (5%); no patients received an LV lead
n the inferior region. Thirteen patients had an apical LV
ead position and were excluded from further analysis.
oncordant versus discordant LV lead position. One-
undred fifty-three patients (63%) had an LV lead position
atient Characteristics
Table 1 Patient Characteristics
All Patients (n  257)
Age (yrs) 66 10
Gender (male/female) 211/46
NYHA functional class (III/IV) 232/25
Ischemic etiology 148 (58%)
QRS duration (ms) 161 33
LBBB 181 (70%)
SR/atrial fibrillation/paced 208/29/30
LVEF (%) 24 7
LVEDV (ml) 235 86
LVESV (ml) 182 76
MR (moderate-to-severe) 46 (18%)
LV dyssynchrony (ms) 177 117
Medication
Anticoagulants 225 (88%)
Diuretics 219 (85%)
ACE inhibitors 232 (90%)
Beta-blockers 176 (68%)
Spironolactone 114 (44%)
CE  angiotensin-converting enzyme; LBBB  left bundle branch block; LV  left ventricular;
VEDV  left ventricular end-diastolic volume; LVEF  left ventricular ejection fraction; LVESV 
eft ventricular end-systolic volume; MR  mitral regurgitation; NYHA  New York Heart Associa-
ion; SR  sinus rhythm.
Figure 2 Distribution of Site of Latest Activation
ANT  anterior left ventricular segment; ANT-SEPT  anteroseptal left ventricu-
lar segment; INF  inferior left ventricular segment; LAT  lateral left ventricu-
lar segment; LV  left ventricular; POST  posterior left ventricular segment;
SEPT  septal left ventricular segment.hocated in the latest activated region, whereas 91 patients
37%) had a discordant LV lead position. Baseline charac-
eristics were comparable between the 2 groups, except for a
ignificantly shorter QRS duration and more often ischemic
tiology in patients with discordant LV lead positions
Table 2).
-month clinical follow-up after CRT. After 6 months of
RT, 152 patients (62%) showed an improvement of at
east 1 NYHA functional class (106 patients showed an
mprovement of 1 NYHA class, 46 patients showed an
mprovement of 2 NYHA classes, p  0.001 vs. baseline).
he quality-of-life score improved from 39  18 to 23 
8, and exercise capacity improved as indicated by an
ncrease in 6-min walking distance from 292  120 m to
88  131 m (both p  0.001). In addition, LVEF
mproved from 23  7% to 31  9% (p  0.001), with a
eduction in LVEDV (236  85 ml to 204  80 ml, p 
.001) and LVESV (183  75 ml to 144  70 ml, p 
.001).
-month CRT response versus LV lead position. After 6
onths of CRT, patients with a concordant LV lead
osition demonstrated significant improvements in echocar-
iographic parameters; LVEDV decreased from 242  92
l to 194 83 ml, LVESV from 189 83 ml to 134 71
l, and, consequently, LVEF increased from 23  7% to
3  9% (all p  0.001). However, patients with a
iscordant LV lead position showed no significant reduction
n LV volumes (LVEDV from 225 71 ml to 220 70 ml
nd LVESV from 172  61 ml to 162  63 ml, both p 
S) and no improvement in LVEF (from 24 7% to 27
%, p  NS) (Fig. 3).
ong-term prognosis versus LV lead position. Mean
uration of follow-up was 32  16 months (range 3 to 92
onths). There were 55 hospitalizations for decompensated
aseline Characteristics Between Patients Withoncordant nd Discordant LV Lead Posi ions
Table 2 Baseline Characteristics Between Patients WithConcordant and Discordant LV Lead Positions
Variable
Concordant
LV Lead Position
(n  153)
Discordant
LV Lead Position
(n  91) p Value
Age (yrs) 67 10 65 10 0.3
Gender (male/female) 120/33 79/12 0.1
NYHA functional class
(III/IV)
140/13 81/10 0.5
Ischemic etiology 75 (49%) 67 (74%) 0.001
QRS duration (ms) 164 31 154 34 0.02
LBBB 114 (75%) 66 (73%) 0.4
SR/atrial fibrillation/
paced
121/10/22 87/11/19 0.6
LVEF (%) 23 7 24 7 0.3
LVEDV (ml) 242 92 225 71 0.1
LVESV (ml) 189 83 172 61 0.1
MR (moderate-to-
severe)
24 (16%) 17 (19%) 0.6
LV dyssynchrony (ms) 189 118 160 119 0.1
bbreviations as in Table 1.eart failure in 25 patients (10%). Patients were hospitalized
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LV Lead Position and Response to CRT October 21, 2008:1402–94  15 months (range 1 to 55 months) after CRT
mplantation. Furthermore, 56 patients died (23%) after a
ean follow-up of 20 14 months (range 2 to 55 months),
nd 1 patient underwent heart transplantation.
Hospitalization rates for decompensated heart failure in
he 2 groups are shown in Figure 4A. During follow-up,
atients with a discordant LV lead position experienced
ore hospitalizations for decompensated heart failure as
ompared with patients with a concordant LV lead position
Figure 3
Echocardiographic Response After CRT in Patients
With Concordant LV Lead Positions (n  153) and
Patients With Discordant LV Lead Positions (n  91)
Open bars  baseline; solid bars  follow-up. *p  0.001. CRT  cardiac
resynchronization therapy; LV  left ventricular; LVEDV  left ventricular end-
diastolic volume; LVEF  left ventricular ejection fraction; LVESV  left ventric-
ular end-systolic volume.Figure 4 Survival and Event Curves
After CRT According to LV Lead Position
(A) Hospitalizations for heart failure, (B) survival, and (C) event-free survival
including death, heart transplantation, and hospitalization for heart failure.
Abbreviations as in Figure 3.
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October 21, 2008:1402–9 LV Lead Position and Response to CRT20 vs. 35 hospitalizations, p 0.04). However, the number
f patients who were hospitalized was not significantly
ifferent among both groups as demonstrated by Figure 4A.
t 24 months of follow-up, hospitalization rates were,
espectively, 4% and 7%. However, during long-term
ollow-up, a trend for more hospital admissions in the
iscordant group was noted (at 48 months, respectively,
2% vs. 26%) (Fig. 4A).
Mortality rates for the 2 groups are shown in Figure 4B.
mportantly, 13 patients (14%) in the discordant patient
roup already died before the 6-month follow-up evaluation
s compared with 1 patient (1%) in the concordant group
p  0.001). Furthermore, 12- and 24-month survival rates
or patients with concordant LV lead positions were 94%
nd 85%, respectively; in patients with discordant LV lead
ositions, the 12- and 24-month survival rates were 90%
nd 79%, respectively (Fig. 4B).
The cumulative event rates of the primary end point
combined for death, hospitalization for heart failure, and
eart transplantation) in both groups are shown in Figure
C. The 12- and 24-month event-free survival rates were
uite similar in patients with a concordant LV lead position
s compared with those in the discordant group; respec-
ively, 9% versus 11% at 12 months and both 19% at 24
onths of follow-up. However, longer follow-up revealed a
orse outcome in patients with a discordant LV lead
osition; 3-year event-free survival is 57% in the discordant
atient group versus 78% in the concordant group.
Univariate analysis revealed that a concordant lead posi-
ion was no predictor of primary outcome within the first 24
onths of follow-up (HR: 0.96, 95% CI: 0.527 to 1.758,
 0.9). After 24 months, however, both uni- and
ultivariate analysis revealed that concordant lead position
as an independent predictor of hospitalization-free sur-
ival (HR: 0.22, 95% CI: 0.078 to 0.623, p  0.004).
iscussion
he findings of the present study can be summarized as
ollows: 1) patients who are candidates for CRT exhibit
arying sites of latest mechanical activation; 2) in one-third
f patients undergoing CRT, the position of the LV lead
id not match the site of latest mechanical activation on
chocardiography; and 3) a match between LV lead position
nd site of latest mechanical activation resulted in a better
chocardiographic response after 6 months of CRT, with a
uperior long-term outcome after CRT.
mportance of LV lead position in CRT. It has been
uggested that 20% to 30% of patients do not respond to
RT when a clinical end point is used (e.g., improvement in
YHA functional class, quality-of-life score, and so on);
owever, when reverse LV remodeling is considered as an
nd point, the nonresponse rate may be as high as 40% to
0% (2,6,7). Several studies have demonstrated that the key
echanism of benefit from CRT is the presence of baseline
echanical LV dyssynchrony as assessed with echocardiog- taphy and its subsequent reduction after CRT implantation
5,27,30). In this perspective, the position of the LV pacing
ead is important. A recent animal study using magnetic
esonance imaging highlighted that regions with maximal
esynchronization after CRT also exhibited maximum
ain in systolic LV function; these regions were referred
o as the “sweet spot” and may be the optimal regions for
he LV lead (31).
With the more advanced echocardiographic techniques,
dequate identification of the region of latest mechanical
ctivation is possible, and recent data emphasized that the
ite of latest activation may vary significantly with 67%
aving the (postero)lateral wall as site of latest activation,
ut 33% having different regions of latest activation (32).
imilarly in the current study, 2D speckle tracking radial
train analysis was used to assess the site of latest mechanical
ctivation. In the majority of patients (n  177), the
osterolateral region was the site of latest mechanical
ctivation, whereas one-third of the patients (n  80)
evealed another region of latest mechanical activation.
Recent studies in small patient groups have indeed shown
hat patients with a concordance between the LV lead
osition and the site of late mechanical activation responded
ignificantly better to CRT, as compared with patients with
iscordance between LV lead position and the site of latest
ctivation. Ansalone et al. (13) evaluated 31 patients under-
oing CRT and demonstrated that patients (42%) who were
aced at the site of latest activation (according to tissue
oppler echocardiography) showed significant improve-
ents in LVESV, LVEF, and exercise tolerance after 1
eek of CRT, whereas patients paced at any other site
58%) showed no improvement. Longer follow-up was
btained in 2 studies, both using 2D strain analysis to
etermine the site of latest mechanical activation. Suffoletto
t al. (25) demonstrated that patients with a concordance
etween the LV lead position and the site of latest activation
ad a larger increase in LVEF at mid-term follow-up as
ompared with patients with a discordance (10  5% vs.
 5%, p  0.05). Becker at al. (16) confirmed these
ndings and reported that the distance between the site of
atest mechanical activation and the actual pacing site was
redictive of reverse LV remodeling at 10-month follow-up.
urphy et al. (15) used a more sophisticated approach with
D tissue synchronization imaging; the patients were di-
ided into 3 groups according to the relation between the
V lead position and the area of latest mechanical activa-
ion. The greatest hemodynamic and clinical benefit from
RT was observed in patients who were paced at the site of
atest mechanical activation, whereas the response was less
n patients with the LV lead adjacent to the site of latest
echanical activation and absent in patients with the LV
ead placed remote from the site of latest mechanical
ctivation.
The current study evaluated a large cohort of patients
ndergoing CRT (n  257) and confirmed the aforemen-
ioned findings; a greater echocardiographic improvement
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LV Lead Position and Response to CRT October 21, 2008:1402–9reverse LV remodeling and increase in LVEF) was noted in
atients with a concordant LV lead position as compared
ith that in patients with a discordant LV lead position.
linically more important, however, is whether concor-
ance or discordance between LV lead position and the site
f latest mechanical activation has prognostic value. Regard-
ng hospitalizations for heart failure, a trend for more
dmissions in the discordant group was noted. Importantly,
ortality was significantly lower in the patients with con-
ordant LV lead position (15% vs. 21% at 24 months,
og-rank p  0.048). Moreover, a concordant LV lead
osition appeared to be an independent predictor of the
ombined end point of hospitalization and mortality after
ong-term CRT.
linical implications. The current study further supports
he importance of the LV lead position in CRT. With
ophisticated echocardiographic techniques, including tissue
oppler imaging and speckle tracking 2D radial strain
maging, it is possible to locate (before device implantation)
he site of latest activation, which may even be further
ptimized by 3D echocardiogram techniques. Ideally, posi-
ioning of the LV pacing lead could thus be guided by
chocardiography during the CRT implantation. However,
t is important to realize that LV lead positioning may be
imited by anatomical and technical factors including pres-
nce, accessibility, and lead stability within the appropriate
egion of the appropriate vein. Venous anatomy can be
btained during the procedure with retrograde venography
ut is also possible with noninvasive imaging using multi-
lice computed tomography before CRT implantation (33).
he precise incidence of suitable veins for CRT is not
nown and may differ between patients with ischemic and
onischemic cardiomyopathy (34). When the site of latest
ctivation is not in the region of suitable veins, surgical LV
ead positioning may be considered, using limited left-
ateral thoracotomy with direct epicardial LV lead place-
ent (35). Ideally, one could thus integrate the information
rom echocardiography (latest mechanical activation) and
ultislice computed tomography (venous anatomy) to de-
ermine the approach. In addition, the presence of postero-
ateral scar tissue appeared to be an important factor for
onresponse after CRT (36). However, assessment of scar
issue was not routinely performed in the current study
opulation. Still, prospective large studies are needed com-
aring empiric and guided LV lead implantation (targeted
t the site of latest activation).
onclusions
ositioning of the LV pacing lead at the site of latest
echanical activation resulted in significant reverse LV
emodeling and increase in LVEF after 6 months of CRT,
hereas discordant LV lead position did not result in
chocardiographic improvement. Moreover, long-term
rognosis was significantly better in patients with a concor-
ant LV lead position; a concordant LV lead position
1ppeared to be an independent predictor of outcome (com-
ined end point of hospitalization and death) after long-
erm CRT.
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